亚太地区透皮医疗贴剂市场预测至 2028 年 - COVID-19 影响和区域分析 - 按类型(单层药物粘合剂、多层药物粘合剂、储库、蒸气贴剂和基质)、应用(神经科)病情、疼痛管理、戒烟、心血管疾病、激素治疗等)和分销渠道(医院药房、零售药房和在线药房)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2028


No. of Pages: 158    |    Report Code: BMIRE00028751    |    Category: Life Sciences

Asia Pacific Transdermal Medical Patch Market

亚太地区透皮医疗贴剂市场预计将从2023年的21.2631亿美元增长到2028年的27.4432亿美元。预计2023年至2028年的复合年增长率为5.2%。    

智能贴剂和三维 (3D) 打印贴剂的进步推动亚太地区透皮医疗贴剂市场

透皮给药途径是新颖的,是持续给药的可靠手段之一。随着这一领域的大量研究的开展以及研究人员对这种药物输送形式的兴趣日益浓厚,预计进入市场的透皮贴剂数量将急剧增加。几十年来,透皮贴剂引起了人们的关注,并被用来输送尼古丁、芬太尼、硝酸甘油和可乐定等药物来治疗各种疾病或病症。

根据一项名为“具有高透明度、粘性、止血性的智能水凝胶贴片,用于糖尿病足溃疡的全方位治疗和血糖监测”,发表于2022年,科学家开发了一种智能贴片,用于监测和治疗糖尿病足溃疡。该系统由具有超高透明度聚合物网络的导电水凝胶贴片制成。

研究人员正在使用 3D 打印技术来创建定制的透皮贴片(例如 3D 打印贴片)用于伤口愈合)根据患者的需求量身定制。 Jang 等人的一项研究中。 2022 年发表的题为“用于组织工程应用的明胶甲基丙烯酸酯水凝胶—材料改性综述”,对甲基丙烯酸明胶 (GelMA) 进行了测试,将其作为具有可调物理性质的可行选择。由于水凝胶油墨的剪切稀化特性,使用 3D 生物打印机成功打印了含有血管内皮生长因子 (VEGF) 模拟肽的 GelMA 水凝胶。水凝胶贴片的 3D 结构具有高孔隙率和吸水特性。 VEGF肽从水凝胶贴片中缓慢释放,可促进细胞活力、增殖和管状结构形成,表明3D Gel-MA-VEGF水凝胶贴片可用于伤口敷料。

<在这项研究中,使用不同比例的两种液体单体——聚乙二醇二丙烯酸酯(PEGDA)和乙烯基吡咯烷酮(VP)——来提高最终聚合物的机械强度、聚合速率和溶胀速率。树脂上的最佳载药量表明 AHP-3 在整个制造过程中保持稳定,并且对最终聚合物的物理性能没有影响。使用 3D 扫描面部模型,在计算机辅助设计软件中设计个性化贴片,并使用数字光处理 3D 打印机以优化树脂制造。所制备的透皮贴剂的体外表征显示其能够穿透人体尸体皮肤,并且在压缩后仍保持完整。

亚太透皮医疗贴剂市场概览

亚太地区的透皮医疗贴剂市场分为澳大利亚、中国、印度、日本、韩国和亚太地区其他地区。该区域的增长归因于对癌症和基因突变的研究不断增长、疾病模型的增加以及提供透皮医疗贴剂的市场参与者的发展。发展医疗保健设施、日益老龄化的人口分享与干细胞技术相关的关键事实以及增加与外国实体的合作伙伴关系等因素可能会在预测期内进一步推动市场增长。

亚太地区透皮医疗贴剂市场收入及预测至 2028 年(百万美元)

         

亚太地区透皮医疗贴剂市场细分

亚太地区透皮医疗贴剂贴剂市场分为类型、应用、分销渠道和国家。

根据类型,亚太地区透皮医疗贴剂市场分为单层药物粘合剂、多层药物粘合剂、储库、蒸气贴片和基质。 2023年,基质细分市场在亚太地区透皮医疗贴剂市场中占据最大市场份额。

根据应用,亚太地区透皮医疗贴剂市场分为神经系统疾病、疼痛等管理、戒烟、心血管疾病、激素治疗等。疼痛管理细分市场在 2023 年占据最大的市场份额。

根据分销渠道,亚太地区透皮医疗贴剂市场分为医院药房、零售药房和在线药房药房。 2023 年,医院药房细分市场占据最大市场份额。

按国家/地区划分,亚太地区透皮医疗贴剂市场分为澳大利亚、中国、印度、日本、韩国以及亚太地区其他地区。日本在 2022 年占据市场份额主导地位。

Boehringer Ingelheim International GmbH、Endo International Inc、Hisamitsu Pharmaceutical Co Inc、Johnsons and Johnsons、Medline Industries LP、Novartis AG、Teva Pharmaceutical Industries Ltd. 和 Viatris Inc 是该地区透皮医疗贴剂市场的领先公司。    



Asia Pacific Transdermal Medical Patch Strategic Insights

Strategic insights for Asia Pacific Transdermal Medical Patch involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-transdermal-medical-patch-market-strategic-framework.webp
Get more information on this report

Asia Pacific Transdermal Medical Patch Report Scope

Report Attribute Details
Market size in 2023 US$ 2,126.31 Million
Market Size by 2028 US$ 2,744.32 Million
Global CAGR (2023 - 2028) 5.2%
Historical Data 2021-2022
Forecast period 2024-2028
Segments Covered By 类型
  • 单层药物胶粘剂
  • 多层药物胶粘剂
  • 储药器
  • 蒸气贴剂
  • 基质
By 应用
  • 神经系统疾病
  • 疼痛管理
  • 戒烟
  • 心血管疾病
  • 激素治疗
By 分销渠道
  • 医院药房
  • 零售药房
  • 网上药房
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Hisamitsu Pharmaceutical Co Inc
  • Medline Industries LP
  • Johnsons and Johnsons
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc
  • Endo International Inc
  • Boehringer Ingelheim International GmbH
  • Get more information on this report

    Asia Pacific Transdermal Medical Patch Regional Insights

    The regional scope of Asia Pacific Transdermal Medical Patch refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-transdermal-medical-patch-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Transdermal Medical Patch Market

    1. Hisamitsu Pharmaceutical Co Inc
    2. Medline Industries LP
    3. Johnsons and Johnsons
    4. Novartis AG
    5. Teva Pharmaceutical Industries Ltd.
    6. Viatris Inc
    7. Endo International Inc
    8. Boehringer Ingelheim International GmbH
    Frequently Asked Questions
    How big is the Asia Pacific Transdermal Medical Patch Market?

    The Asia Pacific Transdermal Medical Patch Market is valued at US$ 2,126.31 Million in 2023, it is projected to reach US$ 2,744.32 Million by 2028.

    What is the CAGR for Asia Pacific Transdermal Medical Patch Market by (2023 - 2028)?

    As per our report Asia Pacific Transdermal Medical Patch Market, the market size is valued at US$ 2,126.31 Million in 2023, projecting it to reach US$ 2,744.32 Million by 2028. This translates to a CAGR of approximately 5.2% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Transdermal Medical Patch Market report typically cover these key segments-

  • 类型 (单层药物胶粘剂, 多层药物胶粘剂, 储药器, 蒸气贴剂, 基质)
  • 应用 (神经系统疾病, 疼痛管理, 戒烟, 心血管疾病, 激素治疗)
  • 分销渠道 (医院药房, 零售药房, 网上药房)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Transdermal Medical Patch Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Transdermal Medical Patch Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2028
  • Who are the major players in Asia Pacific Transdermal Medical Patch Market?

    The Asia Pacific Transdermal Medical Patch Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Hisamitsu Pharmaceutical Co Inc
  • Medline Industries LP
  • Johnsons and Johnsons
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc
  • Endo International Inc
  • Boehringer Ingelheim International GmbH
  • Who should buy this report?

    The Asia Pacific Transdermal Medical Patch Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Transdermal Medical Patch Market value chain can benefit from the information contained in a comprehensive market report.